Ingxoxo emfushane ngocwaningo lwe-Ashwagandha

Ucwaningo olusha lomtholampilo womuntu lisebenzisa ukukhishwa kwe-ashwagandha kwekhwalithi ephezulu, okunelungelo lobunikazi, i-Wintolytin, ukuhlola imiphumela yayo emihle ekukhathaleni nasekucindezelekeni.
Abacwaningi bahlole ukuphepha kwe-ashwagandha kanye nomthelela wayo ekukhathaleni okubonwayo kanye nengcindezi emadodeni nabesifazane abanempilo abayi-111 abaneminyaka engama-40-75 abahlangabezane namazinga aphansi wamandla kanye nengcindezi emaphakathi kuya kokuphezulu okucatshangwayo esikhathini esingamaviki ayi-12.Ucwaningo lusebenzise umthamo wama-200 mg we-ashwagandha kabili ngosuku.
Imiphumela ibonise ukuthi ababambiqhaza abathatha i-ashwagandha bathole ukwehliswa okukhulu kwama-45.81% kuzikolo zomhlaba wonke ze-Chalder Fatigue Scale (CFS) kanye nokwehliswa kwengcindezi ngo-38.59% (okucatshangwa ukuthi isikali sokucindezeleka) uma kuqhathaniswa nesisekelo ngemva kwamaviki angu-12..
Eminye imiphumela ibonise ukuthi amaphuzu angokomzimba kuHlelo Lolwazi Lwezilinganiso Zomphumela Obikiwe Isiguli (PROMIS-29) anyuke (athuthukisiwe) ngo-11.41%, amaphuzu angokwengqondo ku-PROMIS-29 (athuthukisiwe) ehle ngo-26.30% futhi anda ngo-9 .1% uma kuqhathaniswa ne-placebo. .Ukuhluka kwesilinganiso senhliziyo (HRV) kwehle ngo-18.8%.
Isiphetho salolu cwaningo sibonisa ukuthi i-ashwagandha inamandla okusekela indlela ye-adaptogenic, ukulwa nokukhathala, ukuvuselela, nokukhuthaza i-homeostasis nokulinganisela.
Abacwaningi abathintekayo ocwaningweni bathi i-ashwagandha inezinzuzo ezibalulekile ezinikeza amandla kubantu abaneminyaka ephakathi nendawo nabadala abakhuluphele ababhekene namazinga aphezulu okucindezeleka nokukhathala.
I-subanalysis yenziwa ukuhlola ama-biomarker ama-hormone kubahlanganyeli besilisa nabesifazane.Ukugxila kwegazi kwe-testosterone yamahhala (p = 0.048) ne-luteinizing hormone (p = 0.002) kukhuphuke kakhulu ngo-12.87% emadodeni athatha i-ashwagandha uma kuqhathaniswa neqembu le-placebo.
Njengoba kunikezwe le miphumela, kubalulekile ukuqhubeka nokutadisha amaqembu abantu abangase bazuze ngokuthatha i-ashwagandha, njengoba imiphumela yayo yokunciphisa ukucindezeleka ingase ihluke kuye ngezici ezifana neminyaka yobudala, ubulili, isimo senkomba yesisindo somzimba, nokunye okuguquguqukayo.
"Siyajabula ukuthi le ncwadi entsha ihlanganisa ubufakazi obusekela i-Vitolitin nendikimba yethu yobufakazi ekhulayo ebonisa ukumiswa kwe-USP kwe-ashwagandha extract," kuchaza uSonya Cropper, iphini likamongameli omkhulu we-Verdure Sciences.U-Cropper uyaqhubeka, "Kunesithakazelo esikhulayo ku-ashwagandha, ama-adaptogens, ukukhathala, amandla nokusebenza kwengqondo."
IVitolitin ikhiqizwa yi-Verdure Sciences futhi isatshalaliswa e-Europe yi-LEHVOSS Nutrition, ingxenye ye-LEHVOSS Group.


Isikhathi sokuthumela: Feb-13-2024